-
-
-
-
-
-
-
Allakos (ALLK) Reports Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
-
-
-
-
-
-
-
Allakos Provides Business Update and Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Allakos (ALLK) Announces Restructuring to Focus on Development of AK006
-
-
-
-
-
-
-
Allakos Provides Business Update and Reports First Quarter 2023 Financial Results
-
-
-
-
-
-
-
Allakos Provides Business Update and Reports Second Quarter 2022 Financial Results
-
-
-
-
-
-
-
Allakos Provides Business Update and Reports Third Quarter 2021 Financial Results
-
-
-
-
-
-
-
Allakos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

